印度宫颈癌患者的存活率--国家癌症登记计划下 11 个基于人口的癌症登记处的调查结果

IF 5 Q1 HEALTH CARE SCIENCES & SERVICES The Lancet regional health. Southeast Asia Pub Date : 2024-05-01 DOI:10.1016/j.lansea.2023.100296
Krishnan Sathishkumar , Jayasankar Sankarapillai , Aleyamma Mathew , Rekha A. Nair , Nitin Gangane , Sushma Khuraijam , Debabrata Barmon , Shashank Pandya , Gautam Majumdar , Vinay Deshmane , Eric Zomawia , Tseten Wangyal Bhutia , Kaling Jerang , Preethi Sara George , Swapna Maliye , Rajesh Laishram , Anand Shah , Shiromani Debbarma , Shravani Koyande , Lalawmpuii Pachuau , Prashant Mathur
{"title":"印度宫颈癌患者的存活率--国家癌症登记计划下 11 个基于人口的癌症登记处的调查结果","authors":"Krishnan Sathishkumar ,&nbsp;Jayasankar Sankarapillai ,&nbsp;Aleyamma Mathew ,&nbsp;Rekha A. Nair ,&nbsp;Nitin Gangane ,&nbsp;Sushma Khuraijam ,&nbsp;Debabrata Barmon ,&nbsp;Shashank Pandya ,&nbsp;Gautam Majumdar ,&nbsp;Vinay Deshmane ,&nbsp;Eric Zomawia ,&nbsp;Tseten Wangyal Bhutia ,&nbsp;Kaling Jerang ,&nbsp;Preethi Sara George ,&nbsp;Swapna Maliye ,&nbsp;Rajesh Laishram ,&nbsp;Anand Shah ,&nbsp;Shiromani Debbarma ,&nbsp;Shravani Koyande ,&nbsp;Lalawmpuii Pachuau ,&nbsp;Prashant Mathur","doi":"10.1016/j.lansea.2023.100296","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Cancer survival data from Population Based Cancer Registries (PBCR) reflect the average outcome of patients in the population, which is critical for cancer control efforts. Despite decreasing incidence rates, cervical cancer is the second most common female cancer in India, accounting for 10% of all female cancers. The objective of the study is to estimate the five-year survival of patients with cervical cancer diagnosed between 2012 and 2015 from the PBCRs in India.</p></div><div><h3>Methods</h3><p>A single primary incidence of cervical cancer cases of 11 PBCRs (2012–2015) was followed till June 30, 2021 (n = 5591). Active follow-ups were conducted through hospital visits, telephone calls, home or field visits, and public databases. Five-year Observed Survival (OS) and Age Standardised Relative Survival (ASRS) was calculated. OS was measured by age and clinical extent of disease for cervical cancers.</p></div><div><h3>Findings</h3><p>The five-year ASRS (95% CI) of cervical cancer was 51.7% (50.2%–53.3%). Ahmedabad urban (61.5%; 57.4%–65.4%) had a higher survival followed by Thiruvananthapuram (58.8%; 53.1%–64.3%) and Kollam (56.1%; 50.7%–61.3%). Tripura had the lowest overall survival rate (31.6%; 27.2%–36.1%). The five-year OS% for pooled PBCRs was 65.9%, 53.5%, and 18.0% for localised, regional, and distant metastasis, respectively.</p></div><div><h3>Interpretation</h3><p>We observed a wide variation in cervical cancer survival within India. The findings of this study would help the policymakers to identify and address inequities in the health system. We re-emphasise the importance of awareness, early detection, and increase the improvement of the health care system.</p></div><div><h3>Funding</h3><p>The National Cancer Registry Programme is funded through intra-mural funding by <span>Indian Council of Medical Research</span>, <span>Department of Health Research, India</span>, <span>Ministry of Health &amp; Family Welfare</span>.</p></div>","PeriodicalId":75136,"journal":{"name":"The Lancet regional health. Southeast Asia","volume":null,"pages":null},"PeriodicalIF":5.0000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772368223001567/pdfft?md5=fd18389e3b382b70e8b70188e58646b0&pid=1-s2.0-S2772368223001567-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Survival of patients with cervical cancer in India – findings from 11 population based cancer registries under National Cancer Registry Programme\",\"authors\":\"Krishnan Sathishkumar ,&nbsp;Jayasankar Sankarapillai ,&nbsp;Aleyamma Mathew ,&nbsp;Rekha A. Nair ,&nbsp;Nitin Gangane ,&nbsp;Sushma Khuraijam ,&nbsp;Debabrata Barmon ,&nbsp;Shashank Pandya ,&nbsp;Gautam Majumdar ,&nbsp;Vinay Deshmane ,&nbsp;Eric Zomawia ,&nbsp;Tseten Wangyal Bhutia ,&nbsp;Kaling Jerang ,&nbsp;Preethi Sara George ,&nbsp;Swapna Maliye ,&nbsp;Rajesh Laishram ,&nbsp;Anand Shah ,&nbsp;Shiromani Debbarma ,&nbsp;Shravani Koyande ,&nbsp;Lalawmpuii Pachuau ,&nbsp;Prashant Mathur\",\"doi\":\"10.1016/j.lansea.2023.100296\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>Cancer survival data from Population Based Cancer Registries (PBCR) reflect the average outcome of patients in the population, which is critical for cancer control efforts. Despite decreasing incidence rates, cervical cancer is the second most common female cancer in India, accounting for 10% of all female cancers. The objective of the study is to estimate the five-year survival of patients with cervical cancer diagnosed between 2012 and 2015 from the PBCRs in India.</p></div><div><h3>Methods</h3><p>A single primary incidence of cervical cancer cases of 11 PBCRs (2012–2015) was followed till June 30, 2021 (n = 5591). Active follow-ups were conducted through hospital visits, telephone calls, home or field visits, and public databases. Five-year Observed Survival (OS) and Age Standardised Relative Survival (ASRS) was calculated. OS was measured by age and clinical extent of disease for cervical cancers.</p></div><div><h3>Findings</h3><p>The five-year ASRS (95% CI) of cervical cancer was 51.7% (50.2%–53.3%). Ahmedabad urban (61.5%; 57.4%–65.4%) had a higher survival followed by Thiruvananthapuram (58.8%; 53.1%–64.3%) and Kollam (56.1%; 50.7%–61.3%). Tripura had the lowest overall survival rate (31.6%; 27.2%–36.1%). The five-year OS% for pooled PBCRs was 65.9%, 53.5%, and 18.0% for localised, regional, and distant metastasis, respectively.</p></div><div><h3>Interpretation</h3><p>We observed a wide variation in cervical cancer survival within India. The findings of this study would help the policymakers to identify and address inequities in the health system. We re-emphasise the importance of awareness, early detection, and increase the improvement of the health care system.</p></div><div><h3>Funding</h3><p>The National Cancer Registry Programme is funded through intra-mural funding by <span>Indian Council of Medical Research</span>, <span>Department of Health Research, India</span>, <span>Ministry of Health &amp; Family Welfare</span>.</p></div>\",\"PeriodicalId\":75136,\"journal\":{\"name\":\"The Lancet regional health. Southeast Asia\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":5.0000,\"publicationDate\":\"2024-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2772368223001567/pdfft?md5=fd18389e3b382b70e8b70188e58646b0&pid=1-s2.0-S2772368223001567-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Lancet regional health. Southeast Asia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2772368223001567\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Lancet regional health. Southeast Asia","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772368223001567","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

摘要

背景基于人群的癌症登记处(PBCR)提供的癌症生存数据反映了人群中患者的平均治疗效果,这对癌症控制工作至关重要。尽管宫颈癌的发病率在下降,但它仍是印度第二大常见的女性癌症,占所有女性癌症的 10%。本研究的目的是估算 2012 年至 2015 年期间在印度 PBCR 诊断出的宫颈癌患者的五年生存率。方法对 11 个 PBCR(2012-2015 年)的宫颈癌病例(n = 5591)进行单一原发病例随访,直至 2021 年 6 月 30 日。通过医院访问、电话访问、家访或实地访问以及公共数据库进行主动随访。计算了五年观察生存期(OS)和年龄标准化相对生存期(ASRS)。宫颈癌的五年观察生存率(95% CI)为 51.7%(50.2%-53.3%)。艾哈迈达巴德市区(61.5%;57.4%-65.4%)的存活率较高,其次是瑟鲁瓦南塔普兰(58.8%;53.1%-64.3%)和科勒姆(56.1%;50.7%-61.3%)。特里普拉邦的总生存率最低(31.6%;27.2%-36.1%)。对于局部转移、区域转移和远处转移,汇总的 PBCR 五年 OS% 分别为 65.9%、53.5% 和 18.0%。这项研究的结果将有助于决策者发现并解决医疗系统中的不公平现象。我们再次强调提高认识、及早发现和加强改善医疗保健系统的重要性。资金来源国家癌症登记计划由印度卫生与家庭福利部卫生研究司印度医学研究理事会提供内部资金。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Survival of patients with cervical cancer in India – findings from 11 population based cancer registries under National Cancer Registry Programme

Background

Cancer survival data from Population Based Cancer Registries (PBCR) reflect the average outcome of patients in the population, which is critical for cancer control efforts. Despite decreasing incidence rates, cervical cancer is the second most common female cancer in India, accounting for 10% of all female cancers. The objective of the study is to estimate the five-year survival of patients with cervical cancer diagnosed between 2012 and 2015 from the PBCRs in India.

Methods

A single primary incidence of cervical cancer cases of 11 PBCRs (2012–2015) was followed till June 30, 2021 (n = 5591). Active follow-ups were conducted through hospital visits, telephone calls, home or field visits, and public databases. Five-year Observed Survival (OS) and Age Standardised Relative Survival (ASRS) was calculated. OS was measured by age and clinical extent of disease for cervical cancers.

Findings

The five-year ASRS (95% CI) of cervical cancer was 51.7% (50.2%–53.3%). Ahmedabad urban (61.5%; 57.4%–65.4%) had a higher survival followed by Thiruvananthapuram (58.8%; 53.1%–64.3%) and Kollam (56.1%; 50.7%–61.3%). Tripura had the lowest overall survival rate (31.6%; 27.2%–36.1%). The five-year OS% for pooled PBCRs was 65.9%, 53.5%, and 18.0% for localised, regional, and distant metastasis, respectively.

Interpretation

We observed a wide variation in cervical cancer survival within India. The findings of this study would help the policymakers to identify and address inequities in the health system. We re-emphasise the importance of awareness, early detection, and increase the improvement of the health care system.

Funding

The National Cancer Registry Programme is funded through intra-mural funding by Indian Council of Medical Research, Department of Health Research, India, Ministry of Health & Family Welfare.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
2.20
自引率
0.00%
发文量
0
期刊最新文献
One health intervention for the control and elimination of scrub typhus, anthrax, and brucellosis in Southeast Asia: a systematic review Point of care lactate for differentiating septic shock from hypovolemic shock in non-ICU settings: a prospective observational study Assessment of public health laboratory preparedness and response in WHO South-East Asia region during the COVID-19 pandemic: lessons learned and future directions Advancing evidence-based decision-making in Bhutan: development of a health technology assessment framework The implications of waiving local clinical trials for drugs in India: a double-edged sword?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1